Want to see SBRA full AI Analyst Report?

Sabra Healthcare REIT (SBRA) Stock Forecast & Price Target

1,120 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

SBRA Analyst Ratings

Moderate Buy

5 Buy

7 Hold

0 Sell

Based on 12 analysts giving stock ratings to

Sabra

Healthcare REIT

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

SBRA Stock 12 Month Forecast

Average Price Target

$22.73

▲(1.64% Upside)

Based on 12 Wall Street analysts offering 12 month price targets for Sabra Healthcare REIT in the last 3 months. The average price target is $22.73 with a high forecast of $27.00 and a low forecast of $19.00. The average price target represents a 1.64% change from the last price of $22.36.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"16":"$16","19":"$19","22":"$22","25":"$25","28":"$28"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":27,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$27.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":22.727272727272727,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$22.73</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":19,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$19.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[16,19,22,25,28],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,21.17,21.61846153846154,22.06692307692308,22.515384615384615,22.963846153846156,23.412307692307692,23.860769230769233,24.30923076923077,24.75769230769231,25.206153846153846,25.654615384615386,26.103076923076923,26.551538461538463,{"y":27,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,21.17,21.289790209790212,21.409580419580422,21.529370629370632,21.64916083916084,21.76895104895105,21.88874125874126,22.00853146853147,22.12832167832168,22.24811188811189,22.367902097902096,22.487692307692306,22.607482517482516,{"y":22.727272727272727,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,21.17,21.003076923076925,20.83615384615385,20.669230769230772,20.502307692307692,20.335384615384616,20.16846153846154,20.001538461538463,19.834615384615386,19.66769230769231,19.50076923076923,19.333846153846153,19.166923076923077,{"y":19,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":17.194,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.261,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.545,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.029,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.725,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.395,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.734,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.278,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.214,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.071,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.05,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.68,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.17,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$27.00

Average Price Target$22.73

Lowest Price Target$19.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Richard Anderson

Cantor Fitzgerald

$22

Hold

-1.61%

Downside

Reiterated

08/10/26

Sabra Healthcare REIT (SBRA) Receives a Hold from Cantor Fitzgerald

Farrell Granath

Bank of America Securities

$25

Buy

11.81%

Upside

Reiterated

08/07/26

Sabra Healthcare REIT (SBRA) Gets a Buy from Bank of America Securities

Dave Rodgers

Raymond James

$23

Hold

2.86%

Upside

Upgraded

08/06/26

Sabra Health Care upgraded to Market Perform from Underperform at Raymond JamesSabra Health Care upgraded to Market Perform from Underperform at Raymond James

Michael Lewis

Truist Financial

―

Buy

―

Reiterated

08/04/26

Analysts Offer Insights on Real Estate Companies: Alexandria Equities (NYSE: ARE) and Sabra Healthcare REIT (NASDAQ: SBRA)

Omotayo Okusanya

Deutsche Bank

$22→$25

Buy

11.81%

Upside

Reiterated

07/22/26

Sabra Health Care price target raised to $25 from $22 at Deutsche BankSabra Health Care price target raised to $25 from $22 at Deutsche Bank

Wes Golladay

Robert W. Baird

$22→$23

Hold

2.86%

Upside

Reiterated

07/22/26

Sabra Health Care price target raised to $23 from $22 at BairdSabra Health Care price target raised to $23 from $22 at Baird

Aaron Hecht

Citizens JMP

$23→$25

Buy

11.81%

Upside

Reiterated

07/22/26

Sabra Health Care price target raised to $25 from $23 at CitizensSabra Health Care price target raised to $25 from $23 at Citizens

Richard Hightower

Barclays

$21

Hold

-6.08%

Downside

Reiterated

07/22/26

Barclays Sticks to Their Hold Rating for Sabra Healthcare REIT (SBRA)

Unknown Analyst

Wells Fargo

Not Ranked

Wells Fargo

$18→$27

Buy

20.75%

Upside

Assigned

07/15/26

Sabra Healthcare REIT (SBRA) Receives a Buy from Wells Fargo

Michael Goldsmith

UBS

$22→$21

Hold

-6.08%

Downside

Assigned

07/08/26

Sabra Health Care price target lowered to $21 from $22 at UBSSabra Health Care price target lowered to $21 from $22 at UBS

Seth Bergey

Citi

$24→$19

Hold

-15.03%

Downside

Downgraded

06/23/26

Sabra Health Care downgraded to Neutral from Buy at CitiSabra Health Care downgraded to Neutral from Buy at Citi

Nicholas Yulico

Scotiabank

$22→$19

Hold

-15.03%

Downside

Reiterated

06/18/26

Sabra Health Care price target lowered to $19 from $22 at ScotiabankSabra Health Care price target lowered to $19 from $22 at Scotiabank

Juan C. Sanabria

BMO Capital

$22→$23

Hold

2.86%

Upside

Reiterated

04/29/26

Analyst Maintains Hold on Sabra, Lifts Price Target to $23 Amid Solid SHOP Performance but Ongoing Credit and Refinancing Risks

Unknown Analyst

Jefferies

Not Ranked

Jefferies

$22

Buy

-1.61%

Downside

Reiterated

12/15/25

Jefferies Keeps Their Buy Rating on Sabra Healthcare REIT (SBRA)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Richard Anderson

Cantor Fitzgerald

$22

Hold

-1.61%

Downside

Reiterated

08/10/26

Sabra Healthcare REIT (SBRA) Receives a Hold from Cantor Fitzgerald

Farrell Granath

Bank of America Securities

$25

Buy

11.81%

Upside

Reiterated

08/07/26

Sabra Healthcare REIT (SBRA) Gets a Buy from Bank of America Securities

Dave Rodgers

Raymond James

$23

Hold

2.86%

Upside

Upgraded

08/06/26

Sabra Health Care upgraded to Market Perform from Underperform at Raymond JamesSabra Health Care upgraded to Market Perform from Underperform at Raymond James

Michael Lewis

Truist Financial

―

Buy

―

Reiterated

08/04/26

Analysts Offer Insights on Real Estate Companies: Alexandria Equities (NYSE: ARE) and Sabra Healthcare REIT (NASDAQ: SBRA)

Omotayo Okusanya

Deutsche Bank

$22→$25

Buy

11.81%

Upside

Reiterated

07/22/26

Sabra Health Care price target raised to $25 from $22 at Deutsche BankSabra Health Care price target raised to $25 from $22 at Deutsche Bank

Wes Golladay

Robert W. Baird

$22→$23

Hold

2.86%

Upside

Reiterated

07/22/26

Sabra Health Care price target raised to $23 from $22 at BairdSabra Health Care price target raised to $23 from $22 at Baird

Aaron Hecht

Citizens JMP

$23→$25

Buy

11.81%

Upside

Reiterated

07/22/26

Sabra Health Care price target raised to $25 from $23 at CitizensSabra Health Care price target raised to $25 from $23 at Citizens

Richard Hightower

Barclays

$21

Hold

-6.08%

Downside

Reiterated

07/22/26

Barclays Sticks to Their Hold Rating for Sabra Healthcare REIT (SBRA)

Unknown Analyst

Wells Fargo

Not Ranked

Wells Fargo

$18→$27

Buy

20.75%

Upside

Assigned

07/15/26

Sabra Healthcare REIT (SBRA) Receives a Buy from Wells Fargo

Michael Goldsmith

UBS

$22→$21

Hold

-6.08%

Downside

Assigned

07/08/26

Sabra Health Care price target lowered to $21 from $22 at UBSSabra Health Care price target lowered to $21 from $22 at UBS

Seth Bergey

Citi

$24→$19

Hold

-15.03%

Downside

Downgraded

06/23/26

Sabra Health Care downgraded to Neutral from Buy at CitiSabra Health Care downgraded to Neutral from Buy at Citi

Nicholas Yulico

Scotiabank

$22→$19

Hold

-15.03%

Downside

Reiterated

06/18/26

Sabra Health Care price target lowered to $19 from $22 at ScotiabankSabra Health Care price target lowered to $19 from $22 at Scotiabank

Juan C. Sanabria

BMO Capital

$22→$23

Hold

2.86%

Upside

Reiterated

04/29/26

Analyst Maintains Hold on Sabra, Lifts Price Target to $23 Amid Solid SHOP Performance but Ongoing Credit and Refinancing Risks

Unknown Analyst

Jefferies

Not Ranked

Jefferies

$22

Buy

-1.61%

Downside

Reiterated

12/15/25

Jefferies Keeps Their Buy Rating on Sabra Healthcare REIT (SBRA)

Stocks with the Highest Top Analyst Consensus in the Real Estate Sector

AHRAmerican Healthcare REIT, Inc.

BEKEKE Holdings Inc. Sponsored ADR Class A

IRMIron Mountain

CTOCTO Realty Growth

RHPRyman

Find stocks in the Real Estate sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sabra Healthcare REIT

3 Months

Michael LewisTruist Financial

Success Rate

12/17 ratings generated profit

Average Return

+4.59%

Copying Michael Lewis's trades and holding each position for 3 Months would result in 70.59% of your transactions generating a profit, with an average return of +4.59% per trade.

1 Year

Michael LewisTruist Financial

Success Rate

11/17 ratings generated profit

Average Return

+12.51%

Copying Michael Lewis's trades and holding each position for 1 Year would result in 64.71% of your transactions generating a profit, with an average return of +12.51% per trade.

2 Years

Michael LewisTruist Financial

Success Rate

14/17 ratings generated profit

Average Return

+22.84%

Copying Michael Lewis's trades and holding each position for 2 Years would result in 82.35% of your transactions generating a profit, with an average return of +22.84% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SBRA Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, SBRA has received 9 Buy Ratings, 8 Hold Ratings, and 1 Sell Ratings. SBRA average Analyst price target in the past 3 months is 22.73.

Each month's total comprises the sum of three months' worth of ratings.

SBRA Financial Forecast

SBRA Earnings Forecast

Next quarter’s earnings estimate for SBRA is $0.17 with a range of $0.15 to $0.19. The previous quarter’s EPS was -$0.10. SBRA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 0.00% of the time in the same period. In the last calendar year SBRA has Performed in-line its overall industry.

SBRA Sales Forecast

Next quarter’s sales forecast for SBRA is $225.56M with a range of $217.50M to $234.10M. The previous quarter’s sales results were $236.59M. SBRA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 62.50% of the time in the same period. In the last calendar year SBRA has Performed in-line its overall industry.

SBRA Stock Forecast FAQ

What is SBRA’s average 12-month price target, according to analysts?

Based on analyst ratings, Sabra Healthcare Reit’s 12-month average price target is 22.73.

What is SBRA’s upside potential, based on the analysts’ average price target?

Sabra Healthcare Reit has 1.64% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is SBRA a Buy, Sell or Hold?

Sabra Healthcare Reit has a consensus rating of Moderate Buy which is based on 5 buy ratings, 7 hold ratings and 0 sell ratings.

What is Sabra Healthcare Reit’s price target?

The average price target for Sabra Healthcare Reit is 22.73. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $27.00 ,the lowest forecast is $19.00. The average price target represents 1.64% Increase from the current price of $22.36.

What do analysts say about Sabra Healthcare Reit?

Sabra Healthcare Reit’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of SBRA?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Sabra Healthcare REIT (SBRA) Stock Forecast & Price Target

SBRA Analyst Ratings

SBRA Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Sabra Healthcare REIT

SBRA Analyst Recommendation Trends

SBRA Financial Forecast

SBRA Earnings Forecast

SBRA Sales Forecast

SBRA Stock Forecast FAQ

Detailed List of Analyst Forecasts